Scribe Biosciences is an early-stage company pioneering technologies to accelerate immunotherapy discoveries through linked functional and genomic profiling of single-cell interactions.
Publications
Team

Russell Cole, PhD
CEO/Co-Founder

Maithreyan Srinivasan, PhD
CSO/Co-Founder


Zev Gartner, PhD
Co-Founder
Adam Abate, PhD
Co-Founder

Justin Madrigal, PhD
Scientist

Nathan Schoepp, PhD
Scientist

Bill Hyun, PhD
Investor

Paul McEwan
Investor
Please drop us a line. We are actively seeking out collaboration and pilot project opportunities.